Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$854K Buy
35,241
+1,996
+6% +$46.5K 0.19% 112
2025
Q1
$842K Buy
33,245
+300
+0.9% +$7.85K 0.22% 103
2024
Q4
$874K Sell
32,945
-3,776
-10% -$102K 0.22% 101
2024
Q3
$1.06M Hold
36,721
0.27% 90
2024
Q2
$1.03M Sell
36,721
-200
-0.5% -$5.51K 0.25% 91
2024
Q1
$1.02M Sell
36,921
-2,100
-5% -$58.3K 0.23% 87
2023
Q4
$1.12M Sell
39,021
-5,100
-12% -$154K 0.3% 80
2023
Q3
$1.46M Sell
44,121
-3,600
-8% -$127K 0.42% 56
2023
Q2
$1.75M Hold
47,721
0.48% 51
2023
Q1
$1.95M Sell
47,721
-208
-0.4% -$8.98K 0.56% 47
2022
Q4
$2.46M Buy
47,929
+1,608
+3% +$77.1K 0.73% 39
2022
Q3
$2.03M Buy
46,321
+1,100
+2% +$53.5K 0.77% 40
2022
Q2
$2.37M Sell
45,221
-300
-0.7% -$15.3K 0.84% 33
2022
Q1
$2.36M Buy
45,521
+5,829
+15% +$302K 0.7% 42
2021
Q4
$2.35M Sell
39,692
-300
-0.8% -$14.9K 0.71% 38
2021
Q3
$1.72M Sell
39,992
-2,009
-5% -$89K 0.59% 49
2021
Q2
$1.65M Sell
42,001
-200
-0.5% -$7.78K 0.58% 51
2021
Q1
$1.53M Buy
42,201
+144
+0.3% +$5.11K 0.55% 54
2020
Q4
$1.55M Sell
42,057
-3,499
-8% -$128K 0.59% 46
2020
Q3
$1.58M Sell
45,556
-501
-1% -$17.6K 0.66% 43
2020
Q2
$1.43M Sell
46,057
-9,221
-17% -$313K 0.63% 49
2020
Q1
$1.71M Buy
+55,278
New +$1.88M 0.9% 30

Other funds holding PFE

J.W. Coons Advisors's PFE Position: Q2 2025 in Review

J.W. Coons Advisors increased its Pfizer (PFE) stake by 6% in Q2 2025, buying an estimated $46.5K and bringing the position to 35,241 shares worth $854K. The position accounts for 0.19% of the portfolio, ranked #112.

J.W. Coons Advisors first reported a position in PFE in Q1 2020 and has held it in 22 quarters since. The position peaked at $2.46M in Q4 2022. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • J.W. Coons Advisors held 35,241 shares of Pfizer worth $854K as of Q2 2025.
  • J.W. Coons Advisors bought 1,996 Pfizer shares in Q2 2025, an estimated $46.5K.
  • Pfizer made up 0.19% of J.W. Coons Advisors's portfolio in Q2 2025, its #112 holding.
  • J.W. Coons Advisors first reported a position in Pfizer in Q1 2020 and has held it in 22 quarters since.
  • J.W. Coons Advisors's Pfizer position peaked at $2.46M in Q4 2022.
  • 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on J.W. Coons Advisors's 13F filing for Q2 2025, filed 5 Aug 2025.